These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 27908756)

  • 1. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
    Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines.
    Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T
    Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells.
    Mapoung S; Pitchakarn P; Yodkeeree S; Ovatlarnporn C; Sakorn N; Limtrakul P
    Chem Biol Interact; 2016 Jan; 244():140-8. PubMed ID: 26689174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
    Gu X; Jiang Y; Qu Y; Chen J; Feng D; Li C; Yin X
    Eur J Med Chem; 2018 Feb; 145():379-388. PubMed ID: 29335204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
    Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
    Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
    Cheon JH; Kim KS; Yadav DK; Kim M; Kim HS; Yoon S
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1176-1182. PubMed ID: 28669723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
    Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
    Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
    Kim MK; Kim Y; Choo H; Chong Y
    Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin.
    Sagnou M; Novikov FN; Ivanova ES; Alexiou P; Stroylov VS; Titov IY; Tatarskiy VV; Vagida MS; Pelecanou M; Shtil AA; Chilov GG
    Eur J Med Chem; 2020 Jul; 198():112331. PubMed ID: 32403017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
    Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity.
    Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA
    ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
    Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.
    Stark M; Assaraf YG
    Oncotarget; 2017 Jul; 8(30):49973-49987. PubMed ID: 28637003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells.
    Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D
    Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.
    Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM
    Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.